Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Eur J Nutr ; 53(7): 1445-56, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24481688

RESUMO

BACKGROUND: Suboptimal vitamin B status might affect cognitive performance in early childhood. We tested the hypothesis that short-term supplementation with folic acid and selected B vitamins improves cognitive function in healthy children in a population with relatively low folate status. METHODS: We screened 1,002 kindergarten children for suboptimal folate status by assessing the total urinary para-aminobenzoylglutamate excretion. Two hundred and fifty low ranking subjects were recruited into a double blind, randomized, controlled trial to receive daily a sachet containing 220 µg folic acid, 1.1 mg vitamin B2, 0.73 mg B6, 1.2 µg B12 and 130 mg calcium, or calcium only for 3 months. Primary outcomes were changes in verbal IQ, short-term memory and processing speed between baseline and study end. Secondary outcomes were urinary markers of folate and vitamin B12 status, acetyl-para-aminobenzoylglutamate and methylmalonic acid, respectively, and, in a subgroup of 120 participants, blood folate and plasma homocysteine. RESULTS: Pre- and post-intervention cognitive measurements were completed by 115 children in the intervention and 122 in the control group. Compared to control, median blood folate increased by about 50% (P for difference, P < 0.0001). Homocysteine decreased by 1.1 µmol/L compared to baseline, no change was seen in the control group (P for difference P < 0.0001) and acetyl-para-aminobenzoylglutamate was 4 nmol/mmol higher compared to control at the end of the intervention (P < 0.0001). We found no relevant differences between the groups for the cognitive measures. CONCLUSION: Short-term improvement of folate and homocysteine status in healthy children does not appear to affect cognitive performance.


Assuntos
Cognição/efeitos dos fármacos , Suplementos Nutricionais , Ácido Fólico/sangue , Homocisteína/sangue , Complexo Vitamínico B/administração & dosagem , Biomarcadores/sangue , Biomarcadores/urina , Cálcio da Dieta/administração & dosagem , Criança , Pré-Escolar , Método Duplo-Cego , Feminino , Ácido Fólico/urina , Alemanha , Humanos , Masculino , Memória de Curto Prazo/efeitos dos fármacos , Ácido Metilmalônico/urina , Vitamina B 12/sangue , Vitamina B 12/urina
2.
J Pediatr Gastroenterol Nutr ; 54(3): 353-63, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22008957

RESUMO

OBJECTIVES: Long-chain polyunsaturated fatty acid (LC-PUFA) enrichment of preterm infant formulas is recommended to meet high demands. Dietary LC-PUFA may inhibit endogenous LC-PUFA synthesis, thus limiting their benefit. We investigated effects of different docosahexaenoic acid (DHA) intakes on plasma and erythrocyte fatty acids and endogenous LC-PUFA synthesis in preterm infants. METHODS: Forty-two preterm infants (birth weight 1000-2200 g) were randomized double-blind to preterm formulas with γ-linolenic acid (0.4%) and arachidonic acid (AA, 0.1%) but different DHA contents (A: 0.04%, B: 0.33%, C: 0.52%); 24 received human milk (HM: 0.51% AA, 0.38% DHA, nonrandomized). Blood was sampled on study days 0, 14, and 28. Uniformly C-labeled linoleic acid (2 mg/kg) and α-linolenic acid (1 mg/kg) were applied orally on day 26 and blood samples collected 48  hours later. RESULTS: On day 28, group A had the lowest and group C the highest plasma phospholipid concentrations of eicosapentaenoic acid and DHA. Erythrocyte phospholipid DHA was lowest in group A, but comparable in groups B, C, and HM. Plasma and erythrocyte AA were lower in formula groups than in HM. DHA intake had no effect on DHA synthesis. LC-PUFA synthesis was lower in HM infants. CONCLUSIONS: DHA supply dose dependently increased plasma DHA. Formula DHA levels of 0.33% matched plasma DHA status of infants fed HM. LC-PUFA synthesis was lower in infants fed HM than formulas with different DHA and low AA contents. With the LC-PUFA supplementation used, DHA in formulas did not inhibit AA or DHA synthesis.


Assuntos
Ácido Araquidônico/sangue , Gorduras na Dieta/sangue , Ácidos Docosa-Hexaenoicos/farmacologia , Ácido Eicosapentaenoico/sangue , Ácido Linoleico/sangue , Fosfolipídeos/sangue , Ácido alfa-Linolênico/sangue , Ácidos Docosa-Hexaenoicos/administração & dosagem , Ácidos Docosa-Hexaenoicos/sangue , Relação Dose-Resposta a Droga , Método Duplo-Cego , Eritrócitos/metabolismo , Ácidos Graxos Insaturados/biossíntese , Feminino , Humanos , Recém-Nascido , Masculino , Leite Humano
3.
J Am Nutr Assoc ; 41(4): 399-406, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-33783319

RESUMO

OBJECTIVE: The impact of a vegan diet on sprint interval exercise performance is unknown. Thus, the purpose of the present study was to compare performance during a sprint interval exercise between omnivores and vegans. METHODS: Nine healthy omnivores (4 men and 5 women) and nine healthy vegans (4 men and 5 women), with similar levels of daily physical activity, performed four bouts (5-min rest between bouts) of a 30-s all-out sprint exercise on a cycle ergometer. Peak power, mean power, fatigue index, and time to reach maximal power output in each bout were recorded. RESULTS: There was a higher peak power in bouts 1 and 2 compared with bouts 3 and 4 (p < 0.02), and a higher mean power in bout 1 compared with bouts 2, 3 and 4 (p < 0.02). However, for all bouts, there were no significant difference between omnivores and vegans in peak power (7.60 ± 1.55 vs. 8.16 ± 1.27, 7.52 ± 1.6 vs 7.61 ± 0.73, 7.00 ± 1.44 vs. 7.00 ± 1.05 and 6.95 ± 1.42 vs. 6.49 ± 0.90 W.kg-1, all p > 0.05) and in mean power (5.35 ± 0.93 vs. 5.69 ± 0.84, 5.10 ± 0.88 vs. 5.21 ± 0.49, 4.79 ± 0.81 vs. 4.79 ± 0.45 and 4.81 ± 0.81 vs. 4.69 ± 0.47 W.kg-1, all p > 0.05). Fatigue index and time to reach maximal power output were not affected by diet or bouts (all p > 0.05). CONCLUSIONS: These findings indicate that a vegan diet does not compromise sprint interval exercise performance.


Assuntos
Dieta Vegana , Veganos , Ergometria , Exercício Físico , Fadiga , Feminino , Humanos , Masculino
4.
Clin Nutr ; 38(6): 2558-2568, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-30598384

RESUMO

BACKGROUND AND AIMS: Long chain polyunsaturated n-3 fatty acids (LC-PUFA) are of functional and structural importance for brain development. Observational studies have shown positive relations between fatty fish consumption and cognitive performance in children, but Results from intervention studies using supplementary n-3 LC-PUFA are conflicting. Salmon is a good source of n-3 LC-PUFA, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). We tested the hypothesis that an increased dietary salmon intake results in better cognitive outcomes than a meat based diet. METHODS: Children (n = 205, age 4-6 years) in this trial were individually randomized to eating meals containing farmed Atlantic salmon or meat three times weekly for 16 weeks. Pre- and post-intervention a cognitive test (Wechsler Preschool and Primary Scale of Intelligence, 3rd edition, WPPSI-III) and a fine-motor coordination test (Nine Hole Peg Test, 9-HPT) were performed. Biochemical analyses included glycerophospholipid fatty acid profiles in plasma and cheek cells, serum 25-hydroxyvitamin D, and urinary iodine concentration. Dietary intake before and during the study were determined using food frequency questionnaires. RESULTS: Intakes of EPA, DHA, vitamin D and iodine were higher in the salmon than the meat group, but on biomarker level only EPA and DHA increased significantly in the salmon group compared to the meat group (p < 0.001). In general linear models no significant differences between the intervention groups were found in the scale scores of the WPPSI-III tests and the 9-HPT. In analyses of the raw scores, the salmon group showed significantly better improvement in two of the eight raw scores compared to the meat group (symbol search p = 0.038, picture concepts p = 0.047). CONCLUSIONS: Intake of farmed Atlantic salmon led to a greater increase of the raw scores of the picture concept and symbol search subtests, while in the six other subtests raw scores were not different between the groups. This might indicate a modest positive association of salmon intake with the performance of preschool children in some subtests evaluating fluid intelligence but does not suggest an influence on global IQ development. CLINICAL TRIAL REGISTRY NUMBER AND WEBSITE: ClinicalTrials.gov registration number: NCT01951937.


Assuntos
Cognição , Dieta , Salmo salar , Alimentos Marinhos , Animais , Criança , Pré-Escolar , Cognição/efeitos dos fármacos , Cognição/fisiologia , Dieta/métodos , Dieta/estatística & dados numéricos , Ácidos Docosa-Hexaenoicos/farmacologia , Feminino , Humanos , Masculino
5.
PLoS One ; 8(2): e56194, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23457526

RESUMO

BACKGROUND: Folate status, as reflected by red blood cell (RCF) and plasma folates (PF), is related to health and disease risk. Folate degradation products para-aminobenzoylglutamate (pABG) and para-acetamidobenzoylglutamate (apABG) in 24 hour urine have recently been shown to correlate with blood folate. AIM: Since blood sampling and collection of 24 hour urine are cumbersome, we investigated whether the determination of urinary folate catabolites in fasted spot urine is a suitable non-invasive biomarker for folate status in subjects before and during folic acid supplementation. STUDY DESIGN AND METHODS: Immediate effects of oral folic acid bolus intake on urinary folate catabolites were assessed in a short-term pre-study. In the main study we included 53 healthy men. Of these, 29 were selected for a 12 week folic acid supplementation (400 µg). Blood, 24 hour and spot urine were collected at baseline and after 6 and 12 weeks and PF, RCF, urinary apABG and pABG were determined. RESULTS: Intake of a 400 µg folic acid bolus resulted in immediate increase of urinary catabolites. In the main study pABG and apABG concentrations in spot urine correlated well with their excretion in 24 hour urine. In healthy men consuming habitual diet, pABG showed closer correlation with PF (rs = 0.676) and RCF (rs = 0.649) than apABG (rs = 0.264, ns and 0.543). Supplementation led to significantly increased folate in plasma and red cells as well as elevated urinary folate catabolites, while only pABG correlated significantly with PF (rs = 0.574) after 12 weeks. CONCLUSION: Quantification of folate catabolites in fasted spot urine seems suitable as a non-invasive alternative to blood or 24 hour urine analysis for evaluation of folate status in populations consuming habitual diet. In non-steady-state conditions (folic acid supplementation) correlations between folate marker (RCF, PF, urinary catabolites) decrease due to differing kinetics.


Assuntos
Suplementos Nutricionais , Ácido Fólico/metabolismo , Ácido Fólico/urina , Adulto , Suplementos Nutricionais/análise , Ácido Fólico/administração & dosagem , Ácido Fólico/sangue , Glutamatos/sangue , Glutamatos/metabolismo , Glutamatos/urina , Homocisteína/sangue , Homocisteína/urina , Humanos , Masculino , Urinálise , Vitamina B 12/sangue , Vitamina B 12/urina , Vitamina B 6/sangue , Vitamina B 6/urina , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa